Reproductive Medicine Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Jiangmen Central Hospital, Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Hum Reprod. 2019 Sep 29;34(9):1788-1798. doi: 10.1093/humrep/dez095.
Is embryo vitrification associated with a higher risk of adverse perinatal outcomes than slow-freezing?
Embryo vitrification was not associated with increased risks of adverse perinatal outcomes of pre-term birth (PTB), low birthweight (LBW), small for gestational age (SGA), large for gestational age (LGA) and macrosomia, as compared to slow-freezing.
Vitrification is becoming a widely adopted technology for embryo cryopreservation with higher embryo survival rate and live birth rate than the slow-freezing technique. However, limited data are currently available on risks of adverse perinatal outcomes following vitrification as compared to that of slow-freezing. The impact of vitrification on perinatal outcomes remains further to be elucidated.
STUDY DESIGN, SIZE, DURATION: Six large reproductive medical centers in Guangdong province, Southeast of China, took part in this multicenter retrospective cohort study. Cohorts of 3199 live born singletons after Day 3 frozen-thawed embryo transfer (FET) cycles with either vitrification or slow-freezing between January 2011 and December 2015 were included in the study. Each patient only contributed one cycle per cohort and vanishing twins were excluded. Propensity score (PS) matching was used to control for potential confounding factors.
PARTICIPANTS/MATERIALS, SETTING, METHODS: All live-born singletons following either a vitrified or a slow-frozen cleavage FET cycle during the period from 2011 to 2015 were analyzed. Perinatal outcomes of PTB, LBW, macrosomia, SGA and LGA were compared. The vitrified and slow-frozen cohorts were matched by propensity scores with a 1:1 ratio accounting for potential confounding factors associated with perinatal outcomes. These variables included baseline demographics (maternal age, BMI, education level, parity, type of infertility and cause of infertility), as well as IVF characteristics (insemination method, endometrial preparation protocol and embryo cryopreservation duration).
A total of 2858 cases from vitrified embryo transfer (ET) and 341 babies from the slow-freezing group were included. After PS matching, 297 pairs of newborns were generated for comparison. The median gestational age was 39 weeks for both cohorts and the birthweights were comparable (3187.7 ± 502.1 g in the vitrified group vs. 3224.6 ± 483.6 in the slow-freezing group, P>0.05). There were no significant differences between the two groups on the incidence of PTB (5.4% vs. 7.7%), LBW (6.7% vs. 5.7%), macrosomia (5.7% vs. 6.1%), SGA (12.5% vs. 8.4%) and LGA (6.4% vs. 8.1%). Parallel logistic regression analysis indicated that vitrification was non-inferior to slow-freezing method in terms of the occurrence of PTB (OR, 0.68 [95% CI, 0.35, 1.31]), LBW (OR, 1.19[0.61-2.32]), macrosomia (OR, 0.94 [0.48-1.86]), SGA (1.55[0.91-2.64]) and LGA (0.78[0.42-1.45]), P>0.05. Sex-stratified PS matching models with multivariable regression analysis further confirmed that vitrification did not increase the risks of above-mentioned adverse perinatal outcomes in either the male or female infant cohort.
LIMITATIONS, REASONS FOR CAUTION: Although the analysis was adjusted for a number of important confounders, the hospital dataset did not contain other potential confounders such as the medical history and obstetrics outcomes of women during pregnancy to allow adjustment. In addition, the current findings are only applicable to cleavage stage FET, but not pronuclei stage or blastocyst stage ET.
Vitrified ET, in comparison with slow-frozen ET, was not associated with increased risks of adverse neonatal outcomes. With its superiority on live birth rates and non-inferiority on safety perinatal outcomes, transition from slow-freezing to the use of vitrification for embryo cryopreservation is reassuring. Nonetheless, future research is needed for the long-term effects of vitrification method on offspring's health outcomes.
STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the National Key Research and Development Program (2016YFC100205), Guangzhou Science and Technology Project (201804020087), Guangdong Province Science and Technology Project (2016A020218008) and Guangdong Provincial Key Laboratory of Reproductive Medicine (2012A061400003). The authors have no conflicts of interest to declare.
胚胎玻璃化冷冻是否比慢速冷冻更易导致不良围产结局?
胚胎玻璃化冷冻与早产(PTB)、低出生体重(LBW)、小于胎龄儿(SGA)、大于胎龄儿(LGA)和巨大儿等不良围产结局的风险增加无关,与慢速冷冻相比。
玻璃化冷冻技术已广泛应用于胚胎冷冻保存,其胚胎存活率和活产率高于慢速冷冻技术。然而,与慢速冷冻相比,目前关于玻璃化冷冻对不良围产结局风险的数据有限。玻璃化冷冻对围产结局的影响仍需进一步阐明。
研究设计、规模、持续时间:中国东南部广东省的 6 家大型生殖医学中心参与了这项多中心回顾性队列研究。纳入了 2011 年至 2015 年间行第 3 天冷冻解冻胚胎移植(FET)周期的 3199 例活产单胎,分别采用玻璃化或慢速冷冻。每个患者在每个队列中仅贡献一个周期,排除了双胎消失。采用倾向评分(PS)匹配来控制潜在的混杂因素。
参与者/材料、设置、方法:分析了 2011 年至 2015 年间行玻璃化或慢速冷冻卵裂期 FET 周期的所有活产单胎。比较了早产、低出生体重、巨大儿、小于胎龄儿和大于胎龄儿的围产结局。玻璃化冷冻组和慢速冷冻组按 PS 进行 1:1 匹配,以考虑与围产结局相关的潜在混杂因素。这些变量包括基线人口统计学特征(母亲年龄、BMI、教育水平、产次、不孕类型和不孕原因)以及 IVF 特征(授精方法、内膜准备方案和胚胎冷冻保存时间)。
玻璃化胚胎转移(ET)组共 2858 例,慢冻组 341 例。经 PS 匹配后,生成 297 对新生儿进行比较。两组的中位孕龄均为 39 周,出生体重相当(玻璃化组为 3187.7±502.1g,慢冻组为 3224.6±483.6g,P>0.05)。两组早产(5.4%比 7.7%)、低出生体重(6.7%比 5.7%)、巨大儿(5.7%比 6.1%)、小于胎龄儿(12.5%比 8.4%)和大于胎龄儿(6.4%比 8.1%)的发生率无显著差异。平行逻辑回归分析表明,玻璃化冷冻法在早产(OR,0.68[95%CI,0.35,1.31])、低出生体重(OR,1.19[0.61-2.32])、巨大儿(OR,0.94[0.48-1.86])、小于胎龄儿(OR,1.55[0.91-2.64])和大于胎龄儿(OR,0.78[0.42-1.45])的发生方面与慢速冷冻法无差异,P>0.05。多变量回归分析的性别分层 PS 匹配模型进一步证实,玻璃化冷冻法在男婴或女婴队列中均未增加上述不良围产结局的风险。
局限性、谨慎原因:尽管该分析调整了许多重要的混杂因素,但医院数据集并未包含其他潜在的混杂因素,如女性在怀孕期间的病史和产科结局,以允许进行调整。此外,目前的研究结果仅适用于卵裂期 FET,而不适用于原核期或囊胚期 ET。
与慢速冷冻相比,玻璃化冷冻 ET 与不良新生儿结局的风险增加无关。由于其活产率的优势和围产结局的非劣效性,从慢速冷冻过渡到胚胎玻璃化冷冻用于冷冻保存是令人放心的。然而,仍需要进一步研究玻璃化法对后代健康结局的长期影响。
研究资金/竞争利益:该研究由国家重点研发计划(2016YFC100205)、广州市科技计划(201804020087)、广东省科技计划(2016A020218008)和广东省生殖医学重点实验室(2012A061400003)资助。作者无利益冲突声明。